Technical Data Sheet
CJC-1295 With DAC
Also Known As: CJC-1295 DAC, CJC 1295 with DAC, CJC1295 DAC, GHRH analog with DAC, CJC-1295 Drug Affinity Complex, DAC-GRF, Modified GHRH long-acting, CJC 1295 extended release, CJC-1295 albumin-binding GHRH, Long-acting GHRH analog, Growth hormone releasing hormone analog DAC, CJC1295 with drug affinity complex, CJC with DAC, Drug Affinity Complex, long acting GHRH
Scan To View Profile
| Evidence Tier | Research Compound |
|---|---|
| Category | Muscle Growth & Performance |
| Class | Long-acting synthetic GHRH analog with Drug Affinity Complex (DAC) albumin-binding moiety |
| Molecular Target | GHRH receptor (GHRHR) on pituitary somatotrophs; sustained GH and IGF-1 elevation |
| Sequence | tetrasubstituted GRF(1-29) + DAC |
| Molecular Weight | ~3647 Da |
| CAS | 446262-90-4 |
| Parent | Growth hormone releasing factor |
| Mechanism | It attaches to a larger protein in your blood (albumin), which stops your body from destroying it quickly. This allows it to constantly knock on the pituitary gland's door to release growth hormone for days. |
| Studied For | GH pulsatile release research, GH-axis anti-aging, Growth hormone deficiency, Extended GH secretion, Anti-aging / longevity via GH axis, Muscle growth via GH axis, Body composition improvement, Fat reduction via GH, Sleep quality enhancement, IGF-1 elevation research, Recovery and repair via GH axis, Bone density via GH stimulation, Collagen synthesis via GH axis, Metabolic rate increase, Adult GH deficiency models, GH secretagogue research, continuous GH release, muscle growth, fat loss, IGF-1 elevation, recovery |
| Administration Route | Injection Only |
| Form | lyophilized |
| Diluent | bacteriostatic or sterile water |
| Storage Temperature | cold, dark |
| Light Sensitive | Yes |
| Freeze / Thaw | avoid |
| Reconstituted Shelf Life | 28 Days |
| Handling Notes | Reactive DAC maleimide is moisture-sensitive. |
| Regulatory | Not FDA-approved; research chemical; WADA S2. |
| Sources |